Facilitating equitable prevention and management of gout for Maori in Northland, New Zealand, through a collaborative primary care approach

被引:18
|
作者
Lawrence, Aniva [1 ,2 ]
Scott, Sharon [1 ,2 ]
Saparelli, Fabio [3 ]
Greville, Georgina [4 ]
Miller, Andrew [5 ]
Taylor, Andrea [6 ]
Gow, Peter [7 ]
机构
[1] Manaia Primary Hlth Org, POB 1878, Whangarei 0140, New Zealand
[2] Te Tai Tokerau Primary Hlth Org, POB 1878, Whangarei 0140, New Zealand
[3] Univ Auckland, Sch Med, Private Bag 92019, Auckland 1142, New Zealand
[4] Middlemore Hosp, Dept Rheumatol, Private Bag 93311, Auckland 1640, New Zealand
[5] Bush Rd Med Ctr, POB 4320, Kamo 0112, Whangarei, New Zealand
[6] Northland Dist Hlth Board, Private Bag 9742, Whangarei 0148, New Zealand
[7] Counties Manukau Dist Hlth Board, Private Bag 94052, South Auckland Mail Cent 2240, New Zealand
关键词
Gout; medications; blood testing; primary health care; Maori health services; Pacific communities;
D O I
10.1071/HC18082
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
INTRODUCTIONThe Gout Stop Programme was developed for primary care in Northland, New Zealand, to address inequitable health outcomes for Maori and Pacific people with gout. AIMThe aim of the programme was to make it easier for clinicians to prescribe urate-lowering treatment, facilitate patient adherence through education and support, and reduce barriers to gout prevention and long-term management. METHODSFrom 2015 to 2017, patients with acute gout who met inclusion criteria were prescribed treatment according to a Gout Stop Pack' option, based on renal function and diabetes status. Patients were monitored by community pharmacists. Gout educators and a Gout Kaiawhina (community support worker) provided education and support to patients and whanau (families). Patient completion of the programme and outcomes, according to target serum urate level, were recorded. Patient experience was documented using a questionnaire and rating scale. RESULTSIn total, 160 clinicians prescribed therapy at 887 patient presentations; 71% were Maori and Pacific patients. The completion rate was 55% in this group and 84% for the non-Maori and non-Pacific group. In the Maori and Pacific group, 40% reached the target serum urate level (<= 0.36 mmol L-1) in 91 days, and 26% required further titration. In the non-Maori/non-Pacific group, these rates were 51% and 19% respectively. Following programme completion, 68% of Maori and Pacific patients and 65% of non-Maori and non-Pacific patients continued to take allopurinol. The 21 patients interviewed rated the programme as excellent or very good. DISCUSSIONCulturally appropriate education and support for patients and the primary care team was essential. Collaboration between prescribers, community pharmacists and support workers reduced barriers to initiating prevention and long-term urate-lowering treatment and urate testing in this high-needs gout population.
引用
收藏
页码:117 / 127
页数:11
相关论文
共 50 条
  • [41] Converting Community Knowledge into Catchment Nutrient Limits: A Constructivist Analysis of a New Zealand Collaborative Approach to Water Management
    Duncan, Ronlyn
    NATURE + CULTURE, 2013, 8 (02): : 205 - 225
  • [42] Virtual Nutrition Counseling in Pediatric Primary Care: An Integrated Approach to the Prevention and Management of Pediatric Obesity
    Mann, Katherine
    DiGiacomo, Rachel
    Mirza, Nazrat
    Vaidya, Susma
    CLINICAL PEDIATRICS, 2024, 63 (12) : 1742 - 1749
  • [43] Meeting New Challenges in the Management of Anemia of Chronic Kidney Disease Through Collaborative Care with Pharmacists
    Bacchus, Shaffeeulah
    O'Mara, Neeta
    Manley, Harold
    Fishbane, Steven
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (11) : 1857 - 1866
  • [44] PROMOTING COLLABORATIVE GOAL SETTING FOR CANCER PREVENTION AMONG PRIMARY CARE PATIENTS: PILOT TESTING A NEW APPLICATION
    Resnick, Daniel
    Bautista, Allison
    Smith, Jazmine
    Jones, Liz
    Xu, Chang
    Schapira, Marilyn M.
    Aysola, Jaya
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S244 - S244
  • [45] Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk
    Tomlin, Andrew M.
    Lloyd, Hywel S.
    Tilyard, Murray W.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (03) : 311 - 319
  • [46] Cardiovascular risk management of different ethnic groups with type 2 diabetes in primary care in New Zealand
    Elley, C. Raina
    Kenealy, Tim
    Robinson, Elizabeth
    Bramley, Dale
    Selak, Vanessa
    Drury, Paul L.
    Kerse, Ngaire
    Pearson, Janet
    Lay-Yee, Roy
    Arroll, Bruce
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (03) : 468 - 473
  • [47] Anaemia in patients with chronic kidney disease: Management with epoetin beta in primary care setting in New Zealand
    Madhan, Krishan K.
    Chamberlain, Michelle
    Anderson, Elizabeth
    NEPHROLOGY, 2008, 13 (05) : 428 - 432
  • [48] BREAKING SAD: IMPROVING CHRONIC ILLNESS THROUGH THE IMPACT COLLABORATIVE CARE MODEL FOR MANAGEMENT OF DEPRESSION IN AN URBAN UNDERSERVED PRIMARY CARE PRACTICE
    Akter, Khaleda
    Blessington, Bill
    Qaiser, Yusra
    Khanam, Arifa
    Al-Bermani, Tarik
    Kumar, Samir
    Dreamer, Lucas
    Williams, Nadia
    Chang, Andrew
    Stevens, David
    Parisi, Andrew
    Lee, Melissa S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S409 - S409
  • [49] Introducing critical Tiriti policy analysis through a retrospective review of the New Zealand Primary Health Care Strategy
    Came, Heather
    O'Sullivan, D.
    McCreanor, T.
    ETHNICITIES, 2020, 20 (03) : 434 - 456
  • [50] A transdisciplinary approach to local waste management in New Zealand: Addressing interrelated challenges through indigenous partnership
    Goven, Joanna
    Langer, E. R.
    Baker, Virginia
    Ataria, James
    Leckie, Alan
    FUTURES, 2015, 73 : 22 - 36